These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 8357960)
1. Dendritic cell activity against primary tumors: an overview. Becker Y In Vivo; 1993; 7(3):187-91. PubMed ID: 8357960 [TBL] [Abstract][Full Text] [Related]
2. Anticancer role of dendritic cells (DC) in human and experimental cancers--a review. Becker Y Anticancer Res; 1992; 12(2):511-20. PubMed ID: 1349798 [TBL] [Abstract][Full Text] [Related]
3. Success and failure of dendritic cell (DC) anticancer activity may be modulated by nitric oxide synthetase (NOS) gene expression: a hypothesis. Becker Y In Vivo; 1993; 7(3):285-8. PubMed ID: 7689349 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591 [TBL] [Abstract][Full Text] [Related]
5. [Dendritic cells and their role in pathology]. Coronato S; Laguens GE; Spinelli OM; Salas MA; Di Girolamo W Medicina (B Aires); 1998; 58(2):209-18. PubMed ID: 9706258 [TBL] [Abstract][Full Text] [Related]
6. Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma. Zijlmans HJ; Fleuren GJ; Baelde HJ; Eilers PH; Kenter GG; Gorter A Cancer; 2007 Feb; 109(3):556-65. PubMed ID: 17177206 [TBL] [Abstract][Full Text] [Related]
7. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network. Bodey B; Bodey B; Kaiser HE In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303 [TBL] [Abstract][Full Text] [Related]
8. Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli. Bechetoille N; André V; Valladeau J; Perrier E; Dezutter-Dambuyant C J Leukoc Biol; 2006 Jul; 80(1):45-58. PubMed ID: 16614258 [TBL] [Abstract][Full Text] [Related]
9. Cytokines in the generation and maturation of dendritic cells: recent advances. Zou GM; Tam YK Eur Cytokine Netw; 2002; 13(2):186-99. PubMed ID: 12101074 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow. Yang S; Darrow TL; Vervaert CE; Seigler HF Cell Immunol; 1997 Jul; 179(1):84-95. PubMed ID: 9259775 [TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells. Hoffmann TK; Meidenbauer N; Müller-Berghaus J; Storkus WJ; Whiteside TL J Immunother; 2001; 24(2):162-71. PubMed ID: 11265774 [TBL] [Abstract][Full Text] [Related]
13. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Hu J; Yuan X; Belladonna ML; Ong JM; Wachsmann-Hogiu S; Farkas DL; Black KL; Yu JS Cancer Res; 2006 Sep; 66(17):8887-96. PubMed ID: 16951206 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice. Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474 [TBL] [Abstract][Full Text] [Related]
15. Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model. Saika T; Satoh T; Kusaka N; Ebara S; Mouraviev VB; Timme TL; Thompson TC Cancer Gene Ther; 2004 May; 11(5):317-24. PubMed ID: 15044961 [TBL] [Abstract][Full Text] [Related]
16. Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response. Srivastava RM; Varalakshmi Ch; Khar A Int Immunol; 2007 May; 19(5):591-607. PubMed ID: 17369187 [TBL] [Abstract][Full Text] [Related]
17. Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages. Satoh E; Li XK; Hara Y; Ogata K; Guo L; Kitazawa Y; Funeshima-Fuji N; Satoh T; Miyagi T; Sugiura W; Yamamoto N; Teramoto K; Arii S; Kimura H Transpl Immunol; 2007 Nov; 18(2):73-84. PubMed ID: 18005848 [TBL] [Abstract][Full Text] [Related]
18. Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors. Ishida T; Oyama T; Carbone DP; Gabrilovich DI J Immunol; 1998 Nov; 161(9):4842-51. PubMed ID: 9794417 [TBL] [Abstract][Full Text] [Related]
19. Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow. Yamaguchi Y; Tsumura H; Miwa M; Inaba K Stem Cells; 1997; 15(2):144-53. PubMed ID: 9090791 [TBL] [Abstract][Full Text] [Related]
20. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Ferlazzo G; Morandi B; D'Agostino A; Meazza R; Melioli G; Moretta A; Moretta L Eur J Immunol; 2003 Feb; 33(2):306-13. PubMed ID: 12548561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]